{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:06:14Z","timestamp":1787061974307,"version":"build-2736575974"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["GM136331"],"award-info":[{"award-number":["GM136331"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["P30CA082709"],"award-info":[{"award-number":["P30CA082709"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006975","name":"Indiana Clinical and Translational Sciences Institute","doi-asserted-by":"publisher","award":["UL1TR002529"],"award-info":[{"award-number":["UL1TR002529"]}],"id":[{"id":"10.13039\/100006975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006733","name":"Indiana University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.omton.2025.200964","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T16:35:11Z","timestamp":1741451711000},"page":"200964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The oligosaccharyltransferase complex is an essential component of multiple myeloma plasma cells"],"prefix":"10.1016","volume":"33","author":[{"given":"Hong Phuong","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enze","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anh Quynh","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh","family":"Lamsal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagannath","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sankalp","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harikrishnan","family":"Hemavathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Abu","family":"Zaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafat","family":"Abonour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Wek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0896-8641","authenticated-orcid":false,"given":"Ngoc Tung","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2025.200964_bib1","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma","volume":"351","author":"Kyle","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omton.2025.200964_bib2","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omton.2025.200964_bib3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1146\/annurev-med-112017-091045","article-title":"New Drugs in Multiple Myeloma","volume":"70","author":"Kunacheewa","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.omton.2025.200964_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20236074","article-title":"Oligosaccharyltransferase: A Gatekeeper of Health and Tumor Progression","volume":"20","author":"Harada","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omton.2025.200964_bib5","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1007\/s00018-015-1881-7","article-title":"Generation and degradation of free asparagine-linked glycans","volume":"72","author":"Harada","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.omton.2025.200964_bib6","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.cell.2006.08.019","article-title":"Glycosylation in cellular mechanisms of health and disease","volume":"126","author":"Ohtsubo","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.omton.2025.200964_bib7","first-page":"2595","article-title":"OST4 is a subunit of the mammalian oligosaccharyltransferase required for efficient N-glycosylation","volume":"126","author":"Dumax-Vorzet","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.omton.2025.200964_bib8","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1016\/j.celrep.2016.11.042","article-title":"TMEM258 Is a Component of the Oligosaccharyltransferase Complex Controlling ER Stress and Intestinal Inflammation","volume":"17","author":"Graham","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.omton.2025.200964_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1097-2765(03)00243-0","article-title":"Oligosaccharyltransferase isoforms that contain different catalytic STT3 subunits have distinct enzymatic properties","volume":"12","author":"Kelleher","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omton.2025.200964_bib10","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.1021\/bi047328f","article-title":"Proteomic analysis of mammalian oligosaccharyltransferase reveals multiple subcomplexes that contain Sec61, TRAP, and two potential new subunits","volume":"44","author":"Shibatani","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.omton.2025.200964_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1126\/science.aar7899","article-title":"Structural basis for coupling protein transport and N-glycosylation at the mammalian endoplasmic reticulum","volume":"360","author":"Braunger","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.omton.2025.200964_bib12","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1038\/ncomms4072","article-title":"Structure of the mammalian oligosaccharyl-transferase complex in the native ER protein translocon","volume":"5","author":"Pfeffer","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2025.200964_bib13","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1126\/science.aaz3505","article-title":"Cryo-electron microscopy structures of human oligosaccharyltransferase complexes OST-A and OST-B","volume":"366","author":"Ramirez","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.omton.2025.200964_bib14","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1158\/0008-5472.CAN-18-0505","article-title":"Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors","volume":"78","author":"Lopez Sambrooks","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2025.200964_bib15","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nchembio.2194","article-title":"Oligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells","volume":"12","author":"Lopez-Sambrooks","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.omton.2025.200964_bib16","doi-asserted-by":"crossref","first-page":"12514","DOI":"10.1073\/pnas.1613884113","article-title":"Efficient CRISPR-mediated mutagenesis in primary immune cells using CrispRGold and a C57BL\/6 Cas9 transgenic mouse line","volume":"113","author":"Chu","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2025.200964_bib17","article-title":"A CRISPR\/Cas9-mediated screen identifies determinants of early plasma cell differentiation","volume":"13","author":"Xiong","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.200964_bib18","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/s41375-018-0036-x","article-title":"Targeting MYC in multiple myeloma","volume":"32","author":"Jovanovic","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.omton.2025.200964_bib19","doi-asserted-by":"crossref","first-page":"29854","DOI":"10.1074\/jbc.M115.664953","article-title":"The Nuclear Factor (Erythroid-derived 2)-like 2 and Proteasome Maturation Protein Axis Mediate Bortezomib Resistance in Multiple Myeloma","volume":"290","author":"Li","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2025.200964_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13050951","article-title":"The Prognostic Value of Whole-Blood PSMB5, CXCR4, POMP, and RPL5 mRNA Expression in Patients with Multiple Myeloma Treated with Bortezomib","volume":"13","author":"Robak","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.omton.2025.200964_bib21","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1182\/blood-2009-03-211045","article-title":"The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome","volume":"115","author":"Driscoll","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.200964_bib22","article-title":"Genetic Analysis of Multiple Myeloma Identifies Cytogenetic Alterations Implicated in Disease Complexity and Progression","volume":"13","author":"Li","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.omton.2025.200964_bib23","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1182\/blood-2006-07-037077","article-title":"Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis","volume":"109","author":"Zhan","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.200964_bib24","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/leu.2010.21","article-title":"Correlation between array-comparative genomic hybridization-defined genomic gains and losses and survival: identification of 1p31-32 deletion as a prognostic factor in myeloma","volume":"24","author":"Chng","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.omton.2025.200964_bib25","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/leu.2011.53","article-title":"Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma","volume":"25","author":"Chng","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.omton.2025.200964_bib26","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1158\/0008-5472.CAN-06-4046","article-title":"Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling","volume":"67","author":"Chng","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2025.200964_bib27","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1182\/blood-2009-09-243980","article-title":"Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid-restricted kinase, GRK6","volume":"115","author":"Tiedemann","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.200964_bib28","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ajhg.2011.12.024","article-title":"DDOST mutations identified by whole-exome sequencing are implicated in congenital disorders of glycosylation","volume":"90","author":"Jones","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omton.2025.200964_bib29","first-page":"3474","article-title":"The oligosaccharyltransferase subunits OST48, DAD1 and KCP2 function as ubiquitous and selective modulators of mammalian N-glycosylation","volume":"125","author":"Roboti","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.omton.2025.200964_bib30","doi-asserted-by":"crossref","first-page":"26094","DOI":"10.1074\/jbc.273.40.26094","article-title":"DAD1 is required for the function and the structural integrity of the oligosaccharyltransferase complex","volume":"273","author":"Sanjay","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omton.2025.200964_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000915","article-title":"Discovery and validation of surface N-glycoproteins in MM cell lines and patient samples uncovers immunotherapy targets","volume":"8","author":"Oldham","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.omton.2025.200964_bib32","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.gpb.2022.01.004","article-title":"SynergyFinder Plus: Toward Better Interpretation and Annotation of Drug Combination Screening Datasets","volume":"20","author":"Zheng","year":"2022","journal-title":"Genom. Proteom. Bioinform."},{"key":"10.1016\/j.omton.2025.200964_bib33","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a032870","article-title":"Role of eIF2alpha Kinases in Translational Control and Adaptation to Cellular Stress","volume":"10","author":"Wek","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.omton.2025.200964_bib34","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.cub.2014.08.007","article-title":"The mTORC1\/S6K1 pathway regulates glutamine metabolism through the eIF4B-dependent control of c-Myc translation","volume":"24","author":"Csibi","year":"2014","journal-title":"Curr. Biol."},{"key":"10.1016\/j.omton.2025.200964_bib35","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1038\/s41388-022-02474-9","article-title":"Asparagine bioavailability regulates the translation of MYC oncogene","volume":"41","author":"Srivastava","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.omton.2025.200964_bib36","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature03205","article-title":"Regulation of cap-dependent translation by eIF4E inhibitory proteins","volume":"433","author":"Richter","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.omton.2025.200964_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-0716-1217-0_5","article-title":"Measuring Translation Efficiency by RNA Immunoprecipitation of Translation Initiation Factors","volume":"2267","author":"Lucchesi","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omton.2025.200964_bib38","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/ph16010111","article-title":"Review on Bortezomib Resistance in Multiple Myeloma and Potential Role of Emerging Technologies","volume":"16","author":"Kozalak","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.omton.2025.200964_bib39","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2007-08-104950","article-title":"Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein","volume":"112","author":"Oerlemans","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.200964_bib40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40170-017-0169-9","article-title":"Bortezomib resistance in multiple myeloma is associated with increased serine synthesis","volume":"5","author":"Zaal","year":"2017","journal-title":"Cancer Metab."},{"key":"10.1016\/j.omton.2025.200964_bib41","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.4161\/cc.20343","article-title":"Bortezomib induces heme oxygenase-1 expression in multiple myeloma","volume":"11","author":"Barrera","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.omton.2025.200964_bib42","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1158\/1078-0432.CCR-10-3367","article-title":"Treatment-induced oxidative stress and cellular antioxidant capacity determine response to bortezomib in mantle cell lymphoma","volume":"17","author":"Weniger","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2025.200964_bib43","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41419-022-04925-3","article-title":"The aspartyl protease DDI2 drives adaptation to proteasome inhibition in multiple myeloma","volume":"13","author":"Op","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omton.2025.200964_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2019.103504","article-title":"XPO1 is a critical player for bortezomib resistance in multiple myeloma: A quantitative proteomic approach","volume":"209","author":"Chanukuppa","year":"2019","journal-title":"J. Proteomics"},{"key":"10.1016\/j.omton.2025.200964_bib45","first-page":"2410","article-title":"Bortezomib promotes apoptosis of multiple myeloma cells by regulating HSP27","volume":"20","author":"Li","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.omton.2025.200964_bib46","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1186\/s12885-017-3891-3","article-title":"N-glycosylation of serum proteins for the assessment of patients with IgD multiple myeloma","volume":"17","author":"Chen","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.omton.2025.200964_bib47","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.bbagen.2019.03.001","article-title":"Serum protein N-glycosylation changes in multiple myeloma","volume":"1863","author":"Zhang","year":"2019","journal-title":"Biochim. Biophys. Acta. Gen. Subj."},{"key":"10.1016\/j.omton.2025.200964_bib48","doi-asserted-by":"crossref","first-page":"912","DOI":"10.3389\/fimmu.2017.00912","article-title":"Altered N-Linked Glycosylation in Follicular Lymphoma and Chronic Lymphocytic Leukemia: Involvement in Pathogenesis and Potential Therapeutic Targeting","volume":"8","author":"Hollander","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.200964_bib49","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1182\/blood.2022015629","article-title":"Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs","volume":"140","author":"Jutzi","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.200964_bib50","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bcp.2011.10.009","article-title":"Proteasome-based mechanisms of intrinsic and acquired bortezomib resistance in non-small cell lung cancer","volume":"83","author":"de Wilt","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.omton.2025.200964_bib51","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/leu.2011.256","article-title":"Impaired bortezomib binding to mutant beta5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells","volume":"26","author":"Franke","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.omton.2025.200964_bib52","first-page":"1675","article-title":"[Primary stenosing cholangitis]","volume":"41","author":"Lawinski","year":"1988","journal-title":"Wiad. Lek."},{"key":"10.1016\/j.omton.2025.200964_bib53","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/bjh.16503","article-title":"Phosphoglycerate dehydrogenase promotes proliferation and bortezomib resistance through increasing reduced glutathione synthesis in multiple myeloma","volume":"190","author":"Wu","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.omton.2025.200964_bib54","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1182\/blood-2009-09-243535","article-title":"Classical and\/or alternative NF-kappaB pathway activation in multiple myeloma","volume":"115","author":"Demchenko","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.omton.2025.200964_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082203","article-title":"Targeting NF-kappaB Signaling for Multiple Myeloma","volume":"12","author":"Wong","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.omton.2025.200964_bib56","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.cell.2024.03.022","article-title":"Positive selection CRISPR screens reveal a druggable pocket in an oligosaccharyltransferase required for inflammatory signaling to NF-\u03baB","volume":"187","author":"Lampson","year":"2024","journal-title":"Cell."},{"key":"10.1016\/j.omton.2025.200964_bib57","article-title":"Protein arginine methyltransferase 1 is a therapeutic vulnerability in multiple myeloma","volume":"14","author":"Nguyen","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2025.200964_bib58","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0119-22.2022","article-title":"Prenatal Opioid Exposure Impairs Endocannabinoid and Glutamate Transmission in the Dorsal Striatum","volume":"9","author":"Grecco","year":"2022","journal-title":"eNeuro"},{"key":"10.1016\/j.omton.2025.200964_bib59","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/978-1-0716-1975-9_10","article-title":"Analysis of Translational Control in the Integrated Stress Response by Polysome Profiling","volume":"2428","author":"Holmes","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omton.2025.200964_bib60","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/B978-0-12-385114-7.00019-2","article-title":"Methods for analyzing eIF2 kinases and translational control in the unfolded protein response","volume":"490","author":"Teske","year":"2011","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.omton.2025.200964_bib61","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.2192","article-title":"Polysome Analysis","volume":"7","author":"Poria","year":"2017","journal-title":"Bio. Protoc."},{"key":"10.1016\/j.omton.2025.200964_bib62","doi-asserted-by":"crossref","first-page":"887","DOI":"10.15252\/embr.201541970","article-title":"The AS-RBM15 lncRNA enhances RBM15 protein translation during megakaryocyte differentiation","volume":"17","author":"Tran","year":"2016","journal-title":"EMBO Rep."}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329925000335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329925000335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:04:19Z","timestamp":1762657459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329925000335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2950329925000335"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2025.200964","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The oligosaccharyltransferase complex is an essential component of multiple myeloma plasma cells","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2025.200964","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"200964"}}